中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

门静脉血栓动物模型的建立和应用

刘壮 陈纪宏 祁兴顺 许向波 诸葛宇征

引用本文:
Citation:

门静脉血栓动物模型的建立和应用

DOI: 10.12449/JCH240105
基金项目: 

国家自然科学基金 (8227034094)

利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:刘壮负责查阅文献、资料分析、撰写论文;诸葛宇征、陈纪宏、许向波参与修改论文;祁兴顺指导撰写文章并最后定稿。
详细信息
    通信作者:

    祁兴顺, xingshunqi@126.com (ORCID: 0000-0002-9448-6739)

Establishment and application of animal models for portal vein thrombosis

Research funding: 

National Natural Science Foundation of China (8227034094)

More Information
    Corresponding author: QI Xingshun, xingshunqi@126.com (ORCID: 0000-0002-9448-6739)
  • 摘要: 门静脉血栓(PVT)是指在肝外门静脉主干和/或肝内门静脉分支内发生的血栓栓塞。PVT是由多种因素共同作用的结果,但其发病机制尚未完全阐明。建立动物模型是研究PVT病理生理机制的重要方法。本文根据不同的动物种类,对现有PVT动物模型的建立方法、原理、优缺点和应用情况进行综述。

     

  • [1] QI X. Portal vein thrombosis: Recent advance[J]. Adv Exp Med Biol, 2017, 906: 229- 239. DOI: 10.1007/5584_2016_118.
    [2] OGREN M, BERGQVIST D, BJÖRCK M, et al. Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23, 796 consecutive autopsies[J]. World J Gastroenterol, 2006, 12( 13): 2115- 2119. DOI: 10.3748/wjg.v12.i13.2115.
    [3] PAN JH, WANG L, GAO FB, et al. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis[J]. Eur J Intern Med, 2022, 104: 21- 32. DOI: 10.1016/j.ejim.2022.05.032.
    [4] TRIPODI A, MANNUCCI PM. The coagulopathy of chronic liver disease[J]. N Engl J Med, 2011, 365( 2): 147- 156. DOI: 10.1056/NEJMra1011170.
    [5] INTAGLIATA NM, CALDWELL SH, TRIPODI A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis[J]. Gastroenterology, 2019, 156( 6): 1582- 1599.e1. DOI: 10.1053/j.gastro.2019.01.265.
    [6] QI XS, HAN GH, FAN DM. Research progress on portal vein occlusion[J]. Natl Med J China, 2014, 94( 6): 473- 475. DOI: 10.3760/cma.j.issn.0376-2491.2014.06.020.

    祁兴顺, 韩国宏, 樊代明. 门静脉阻塞研究进展[J]. 中华医学杂志, 2014, 94( 6): 473- 475. DOI: 10.3760/cma.j.issn.0376-2491.2014.06.020.
    [7] QI X, REN W, de STEFANO V, et al. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2014, 12( 11): 1801- 1812. e 7. DOI: 10.1016/j.cgh.2014.04.026.
    [8] QI XS, de STEFANO V, WANG J, et al. Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: A systematic review and meta-analysis of observational studies[J]. J Gastroenterol Hepatol, 2013, 28( 3): 432- 442. DOI: 10.1111/jgh.12085.
    [9] ZOCCO MA, di STASIO E, de CRISTOFARO R, et al. Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol, 2009, 51( 4): 682- 689. DOI: 10.1016/j.jhep.2009.03.013.
    [10] PATTERSON KA, ZHANG X, WROBLESKI SK, et al. Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects[J]. Thromb Res, 2013, 131( 3): 268- 276. DOI: 10.1016/j.thromres.2012.12.006.
    [11] WOJCIK BM, WROBLESKI SK, HAWLEY AE, et al. Interleukin-6: A potential target for post-thrombotic syndrome[J]. Ann Vasc Surg, 2011, 25( 2): 229- 239. DOI: 10.1016/j.avsg.2010.09.003.
    [12] SINGH I, BURNAND KG, COLLINS M, et al. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: Rescue by normal bone marrow-derived cells[J]. Circulation, 2003, 107( 6): 869- 875. DOI: 10.1161/01.cir.0000050149.22928.39.
    [13] ANDIA ME, SAHA P, JENKINS J, et al. Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis[J]. Arterioscler Thromb Vasc Biol, 2014, 34( 6): 1193- 1198. DOI: 10.1161/ATVBAHA.113.302931.
    [14] WEI YH, SHAO J, SHEN H, et al. The inhibitory role of recombinant P-selectin glycoprotein ligand immunoglobulin G on portal vein thrombosis based on a novel rat model[J]. Exp Ther Med, 2019, 17( 5): 3589- 3597. DOI: 10.3892/etm.2019.7394.
    [15] YAO LL, PAN WZ, GE LF, et al. Establishment and evaluation of rat model with portal vein thrombosis[J]. Sichuan J Anat, 2018, 26( 2): 1- 4. DOI: 10.3969/j.issn.1005-1457.2018.02.001.

    姚露露, 潘闻证, 葛立峰, 等. 门静脉血栓大鼠模型的建立及评价[J]. 四川解剖学杂志, 2018, 26( 2): 1- 4. DOI: 10.3969/j.issn.1005-1457.2018.02.001.
    [16] LI WW. Construction of a rat portal vein thrombosis model and observation of thrombus dynamics[D]. Chengde: Chengde Medical University, 2023. DOI: 10.27691/d.cnki.gcdyx.2023.000402.

    李威威. 大鼠门静脉血栓模型构建和血栓动态观察[D]. 承德: 承德医学院, 2023. DOI: 10.27691/d.cnki.gcdyx.2023.000402.
    [17] ZHANG JY, CHEN WX, SHEN H, et al. Establishment and observation of portal vein thrombosis model in rats[J]. Chin J Gen Surg, 2018, 27( 6): 724- 731. DOI: 10.3978/j.issn.1005-6947.2018.06.011.

    张津瑜, 陈文显, 沈华, 等. 大鼠门静脉系统血栓形成模型的建立和观察[J]. 中国普通外科杂志, 2018, 27( 6): 724- 731. DOI: 10.3978/j.issn.1005-6947.2018.06.011.
    [18] XU M, XUE WL, MA ZH, et al. Resveratrol reduces the incidence of portal vein system thrombosis after splenectomy in a rat fibrosis model[J]. Oxid Med Cell Longev, 2016, 2016: 7453849. DOI: 10.1155/2016/7453849.
    [19] OMOKAWA S, ASANUMA Y, KOYAMA K. Evaluation of hemodynamics and hepatic mitochondrial function on extrahepatic portal obstruction in the rat[J]. World J Surg, 1990, 14( 2): 247-253; discussion 253-254. DOI: 10.1007/BF01664884.
    [20] HE Q, ZHANG SB, ZHU F, et al. Influence of chronic biliary infection on coagulation status in portal vein system in rabbits[J]. Chin J Gen Surg, 2013, 22( 8): 1038- 1042.

    何谦, 张少波, 祝峰, 等. 慢性胆道感染对兔门静脉系统凝血环境的影响[J]. 中国普通外科杂志, 2013, 22( 8): 1038- 1042.
    [21] IDE T, OHNO Y, NAKANUMA Y, et al. Early development of cavernomatous vasculatures in portal venous thrombosis: Morphometric kinetics in rabbit model[J]. Hepatol Res, 2003, 27( 2): 136- 142. DOI: 10.1016/s1386-6346(03)00208-0.
    [22] ITOH K, IEKO M, HIRAGUCHI E, et al. In vivo kinetics of 99mTc labeled recombinant tissue plasminogen activator in rabbits[J]. Ann Nucl Med, 1994, 8( 3): 193- 199. DOI: 10.1007/BF03164997.
    [23] FENG YP, ZHANG FX, NIU LY, et al. Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system[J]. Blood Coagul Fibrinolysis, 2016, 27( 5): 531- 541. DOI: 10.1097/MBC.0000000000000567.
    [24] KNIGHT LC, MAURER AH, AMMAR IA, et al. Tc-99m antifibrin Fab' fragments for imaging venous thrombi: Evaluation in a canine model[J]. Radiology, 1989, 173( 1): 163- 169. DOI: 10.1148/radiology.173.1.2781002.
    [25] KNIGHT LC, MAURER AH, ROMANO JE. Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model[J]. J Nucl Med, 1996, 37( 3): 476- 482.
    [26] LUO DY. Construction of a canine portal vein thrombosis model[D]. Hengyang: University of South China, 2020. DOI: 10.27234/d.cnki.gnhuu.2019.000715.

    罗东阳. 犬门静脉血栓模型的构建[D]. 衡阳: 南华大学, 2020. DOI: 10.27234/d.cnki.gnhuu.2019.000715.
    [27] DENG LM, DENG T, LUO DY, et al. A new modified canine model of portal vein thrombosis[J]. Acta Biochim Biophys Sin, 2021, 53( 2): 265- 268. DOI: 10.1093/abbs/gmaa165.
    [28] PENG CT. The effect of hepatocyte growth factor on the organized reperfusion of canine portal vein thrombosis through the JAK2-STAT3 signaling pathway[D]. Hengyang: University of South China, 2019.

    彭长铁. 肝细胞生长因子通过JAK2-STAT3信号通路对犬门静脉血栓机化再通的影响[D]. 衡阳: 南华大学, 2019.
    [29] SHI WY, WU S, HU LY, et al. Swine model of thrombotic caval occlusion created by autologous Thrombus injection with assistance of intra-caval net knitting[J]. Sci Rep, 2015, 5: 18546. DOI: 10.1038/srep18546.
    [30] ROBINSON VJB, PINEDA GE, SALAH AK, et al. Latex D-dimer signal in in situ femoral vein thrombus in swine and effect of minidose exogenous tissue plasminogen activator bolus[J]. Chest, 2005, 127( 2): 622- 629. DOI: 10.1378/chest.127.2.622.
    [31] GOLDBERG SN, AHMED M, WEINSTEIN J, et al. Low-power transverse ultrasonic treatment of portal vein thrombosis in an animal model[J]. J Vasc Interv Radiol, 2002, 13( 9 Pt 1): 915- 921. DOI: 10.1016/s1051-0443(07)61775-8.
    [32] ZHANG R, LU SX, JIANG YY, et al. A preclinical porcine model of portal vein thrombosis in liver cirrhosis[J]. Biomed Res Int, 2020, 2020: 3086906. DOI: 10.1155/2020/3086906.
    [33] LIU K, MENG JX, FAN XX, et al. Establishment of mesenteric venous thrombosis in a porcine model using a transhepatic endovascular approach[J]. Thromb Res, 2015, 136( 6): 1179- 1184. DOI: 10.1016/j.thromres.2015.10.028.
    [34] ZHU L. Experimental and clinical application research on interventional treatment of portal vein thrombosis[D]. Shanghai: Fudan University, 2011.

    朱樑. 介入途径治疗门静脉系统血栓的实验与临床应用研究[D]. 上海: 复旦大学, 2011.
    [35] ZHANG L, FU JX, SONG P, et al. The safety of Habib VesOpen bipolar radiofrequency ablation catheter used in the treatment of portal vein tumor thrombus:an experimental study in miniature pig models[J]. J Interv Radiol, 2015( 6): 515- 519. DOI: 10.3969/j.issn.1008-794X.2015.06.012.

    张林, 付金鑫, 宋鹏, 等. Habib VesOpen消融导管治疗小型猪模拟门静脉癌栓的安全性研究[J]. 介入放射学杂志, 2015( 6): 515- 519. DOI: 10.3969/j.issn.1008-794X.2015.06.012.
    [36] TIAN RY. Exploratory study on portal vein thrombosis and anticoagulant therapy in patients with liver cirrhosis[D]. Jinan: Shandong University, 2022.

    田瑞渊. 肝硬化门静脉血栓及抗凝治疗的探索性研究[D]. 济南: 山东大学, 2022.
    [37] NG KKC, LAM CM, POON RTP, et al. Delayed portal vein thrombosis after experimental radiofrequency ablation near the main portal vein[J]. Br J Surg, 2004, 91( 5): 632- 639. DOI: 10.1002/bjs.4500.
    [38] CAMPOS J, BRILL A. By word of mouse: Using animal models in venous thrombosis research[J]. Platelets, 2020, 31( 4): 447- 454. DOI: 10.1080/09537104.2019.1678117.
  • 加载中
计量
  • 文章访问数:  408
  • HTML全文浏览量:  106
  • PDF下载量:  80
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-11-22
  • 录用日期:  2023-11-30
  • 出版日期:  2024-01-23
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回